|
In April
2011, ADD-ADHD Cyprus successfully lobbied the Ministry of Health to
provide AD/HD medication free to all low income families.
ADD-ADHD Cyprus also contributed to a report on Disability Rights,
which was produced by the Children's Rights Commission, Ms. Leda
Koursoumba, for Parliament.
In May 2006, ADHD-Europe
submitted its
contribution to the European Commission's Green Paper on
Improving Mental Health. The contribution
stresses the need to promote mental health for AD/HD
sufferers, reduce the burden of AD/HD by providing
adequate prevention, early diagnosis, and appropriate
treatment, and address the stigma, discrimination and
social exclusion that many AD/HD sufferers face across
Europe. ADD-ADHD Cyprus is proud to be an active
member of ADHD-Europe.
ADD-ADHD
Cyprus, in
cooperation with the Patients Rights Movement of Cyprus,
took part in the presentation of "The State of
Patients' Rights in Europe: A Citizen's Report
Monitoring the European Charter of Patients' Rights" at
the European Parliament from February 28 to March 1,
2005. For more information on the project, which
is carried out by the Active Citizenship Network, please
visit the Network's website at
www.activecitizenship.net.
In 2004, ADD-ADHD
Cyprus
successfully lobbied the Ministry of Health to approve
the import of two new drugs for the treatment of
ADD-ADHD -- Concerta, Adderall,
and Straterra. All are long
lasting (up to 12 hours), in contrast to Ritalin (4-6
hours), the only drug allowed previously.
Straterra is available from private pharmacies. |
